- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.46 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x QNG: Lenacapavir(Non-covalent)
- 18 x IOD: IODIDE ION(Non-functional Binders)
IOD.2: 2 residues within 4Å:- Chain A: P.17, R.18
Ligand excluded by PLIPIOD.3: 5 residues within 4Å:- Chain A: E.35, R.173
- Chain E: G.60, G.61, Q.63
Ligand excluded by PLIPIOD.4: 2 residues within 4Å:- Chain A: P.17, N.21
Ligand excluded by PLIPIOD.10: 2 residues within 4Å:- Chain B: P.17, R.18
Ligand excluded by PLIPIOD.11: 5 residues within 4Å:- Chain B: E.35, R.173
- Chain F: G.60, G.61, Q.63
Ligand excluded by PLIPIOD.12: 2 residues within 4Å:- Chain B: P.17, N.21
Ligand excluded by PLIPIOD.18: 2 residues within 4Å:- Chain C: P.17, R.18
Ligand excluded by PLIPIOD.19: 5 residues within 4Å:- Chain C: E.35, R.173
- Chain D: G.60, G.61, Q.63
Ligand excluded by PLIPIOD.20: 2 residues within 4Å:- Chain C: P.17, N.21
Ligand excluded by PLIPIOD.26: 2 residues within 4Å:- Chain D: P.17, R.18
Ligand excluded by PLIPIOD.27: 5 residues within 4Å:- Chain B: G.60, G.61, Q.63
- Chain D: E.35, R.173
Ligand excluded by PLIPIOD.28: 2 residues within 4Å:- Chain D: P.17, N.21
Ligand excluded by PLIPIOD.34: 2 residues within 4Å:- Chain E: P.17, R.18
Ligand excluded by PLIPIOD.35: 5 residues within 4Å:- Chain C: G.60, G.61, Q.63
- Chain E: E.35, R.173
Ligand excluded by PLIPIOD.36: 2 residues within 4Å:- Chain E: P.17, N.21
Ligand excluded by PLIPIOD.42: 2 residues within 4Å:- Chain F: P.17, R.18
Ligand excluded by PLIPIOD.43: 5 residues within 4Å:- Chain A: G.60, G.61, Q.63
- Chain F: E.35, R.173
Ligand excluded by PLIPIOD.44: 2 residues within 4Å:- Chain F: P.17, N.21
Ligand excluded by PLIP- 24 x CL: CHLORIDE ION(Non-functional Binders)
CL.5: 3 residues within 4Å:- Chain A: N.57
- Chain F: R.173
- Ligands: QNG.1
Ligand excluded by PLIPCL.6: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.7: 2 residues within 4Å:- Chain A: R.162, Q.219
Ligand excluded by PLIPCL.8: 4 residues within 4Å:- Chain A: V.27, E.28, G.60, H.62
Ligand excluded by PLIPCL.13: 3 residues within 4Å:- Chain B: N.57
- Chain D: R.173
- Ligands: QNG.9
Ligand excluded by PLIPCL.14: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.15: 2 residues within 4Å:- Chain B: R.162, Q.219
Ligand excluded by PLIPCL.16: 4 residues within 4Å:- Chain B: V.27, E.28, G.60, H.62
Ligand excluded by PLIPCL.21: 3 residues within 4Å:- Chain C: N.57
- Chain E: R.173
- Ligands: QNG.17
Ligand excluded by PLIPCL.22: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.23: 2 residues within 4Å:- Chain C: R.162, Q.219
Ligand excluded by PLIPCL.24: 4 residues within 4Å:- Chain C: V.27, E.28, G.60, H.62
Ligand excluded by PLIPCL.29: 3 residues within 4Å:- Chain C: R.173
- Chain D: N.57
- Ligands: QNG.25
Ligand excluded by PLIPCL.30: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.31: 2 residues within 4Å:- Chain D: R.162, Q.219
Ligand excluded by PLIPCL.32: 4 residues within 4Å:- Chain D: V.27, E.28, G.60, H.62
Ligand excluded by PLIPCL.37: 3 residues within 4Å:- Chain A: R.173
- Chain E: N.57
- Ligands: QNG.33
Ligand excluded by PLIPCL.38: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.39: 2 residues within 4Å:- Chain E: R.162, Q.219
Ligand excluded by PLIPCL.40: 4 residues within 4Å:- Chain E: V.27, E.28, G.60, H.62
Ligand excluded by PLIPCL.45: 3 residues within 4Å:- Chain B: R.173
- Chain F: N.57
- Ligands: QNG.41
Ligand excluded by PLIPCL.46: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.47: 2 residues within 4Å:- Chain F: R.162, Q.219
Ligand excluded by PLIPCL.48: 4 residues within 4Å:- Chain F: V.27, E.28, G.60, H.62
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bester, S.M. et al., Structural and Mechanistic Bases of Viral Resistance to HIV-1 Capsid Inhibitor Lenacapavir. Mbio (2022)
- Release Date
- 2022-07-27
- Peptides
- Capsid protein p24: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
CC
CD
CE
CF
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.46 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x QNG: Lenacapavir(Non-covalent)
- 18 x IOD: IODIDE ION(Non-functional Binders)
- 24 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bester, S.M. et al., Structural and Mechanistic Bases of Viral Resistance to HIV-1 Capsid Inhibitor Lenacapavir. Mbio (2022)
- Release Date
- 2022-07-27
- Peptides
- Capsid protein p24: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
CC
CD
CE
CF
C